This is a Validated Antibody Database (VAD) review about dog CDH3, based on 9 published articles (read how Labome selects the articles), using CDH3 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH3 synonym: cadherin-3; cadherin 15, M-cadherin (myotubule)

Invitrogen
mouse monoclonal (12H6)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Invitrogen CDH3 antibody (Zymed, 12H6) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (12H6)
  • western blot; human; 1:1000
In order to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis, Invitrogen CDH3 antibody (Invitrogen, 12H6) was used in western blot on human samples at 1:1000. J Ovarian Res (2014) ncbi
mouse monoclonal (12H6)
  • western blot; human; fig 4
In order to compare the histological, biological, and molecular features of 2D and 3D epithelial ovarian cancer cultures, Invitrogen CDH3 antibody (Invitrogen, 32-4000) was used in western blot on human samples (fig 4). Lab Invest (2013) ncbi
mouse monoclonal (12H6)
  • immunocytochemistry; human; fig 1
  • immunocytochemistry; mouse; fig 1
  • western blot; mouse; fig 1
In order to elucidate alveolar rhabdomyosarcoma pathogenesis, Invitrogen CDH3 antibody (Invitrogen, 32-4000) was used in immunocytochemistry on human samples (fig 1), in immunocytochemistry on mouse samples (fig 1) and in western blot on mouse samples (fig 1). Oncogene (2013) ncbi
mouse monoclonal (12H6)
  • immunohistochemistry - paraffin section; human; 1:200; fig 7
In order to study the clinicopathologic features of 14 cases of sporadic hybrid oncocytic/chromophobe tumor of the kidney, Invitrogen CDH3 antibody (Zymed, 12H6) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 7). Virchows Arch (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; dog; fig 4
  • western blot; dog; fig 4
In order to study the differentiation and transformation of canine kidney MDCK cells cultured in either a 2D or 3D environment, Invitrogen CDH3 antibody (Invitrogen, 71-7100) was used in immunocytochemistry on dog samples (fig 4) and in western blot on dog samples (fig 4). Lab Invest (2010) ncbi
mouse monoclonal (12H6)
  • western blot; human; fig 6
In order to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling, Invitrogen CDH3 antibody (Zymed, 12H6) was used in western blot on human samples (fig 6). Exp Cell Res (2008) ncbi
mouse monoclonal (12H6)
  • western blot; human; 1:1000; fig 2
In order to assess if selective loss of progesterone receptor A or B affects the invasive capacity of endometrial cancer cells, Invitrogen CDH3 antibody (Zymed, 12H6) was used in western blot on human samples at 1:1000 (fig 2). J Soc Gynecol Investig (2005) ncbi
rabbit polyclonal
In order to demonstrate that p27 is expressed in proliferating cells, Invitrogen CDH3 antibody (Zymed, 71-7100) was used . BMC Clin Pathol (2005) ncbi
Articles Reviewed
  1. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  2. Brueggmann D, Templeman C, Starzinski Powitz A, Rao N, Gayther S, Lawrenson K. Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res. 2014;7:17 pubmed publisher
  3. Lee J, Mhawech Fauceglia P, Lee N, Parsanian L, Lin Y, Gayther S, et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 2013;93:528-42 pubmed publisher
  4. Thuault S, Hayashi S, Lagirand Cantaloube J, Plutoni C, Comunale F, Delattre O, et al. P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness. Oncogene. 2013;32:1876-87 pubmed publisher
  5. Petersson F, Gatalica Z, Grossmann P, Perez Montiel M, Alvarado Cabrero I, Bulimbasic S, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456:355-65 pubmed publisher
  6. Töyli M, Rosberg Kulha L, Capra J, Vuoristo J, Eskelinen S. Different responses in transformation of MDCK cells in 2D and 3D culture by v-Src as revealed by microarray techniques, RT-PCR and functional assays. Lab Invest. 2010;90:915-28 pubmed publisher
  7. Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y, et al. JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008;314:421-9 pubmed publisher
  8. Hanekamp E, Gielen S, De Ruiter P, Chadha Ajwani S, Huikeshoven F, Burger C, et al. Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins. J Soc Gynecol Investig. 2005;12:278-84 pubmed
  9. Troncone G, Martinez J, Iaccarino A, Zeppa P, Caleo A, Russo M, et al. p27Kip1 is expressed in proliferating cells in its form phosphorylated on threonine 187. BMC Clin Pathol. 2005;5:3 pubmed